Bicyclic heterocyclic compound

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9266840
APP PUB NO 20140249151A1
SERIAL NO

14351965

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

To provide a compound useful as an active ingredient of a pharmaceutical composition for treating 11β-hydroxysteroid dehydrogenase type 1-related diseases such as dementia, schizophrenia, depression, pain (particularly, neuropathic pain or fibromyalgia), diabetes (particularly, type II diabetes mellitus), insulin resistance and the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ASTELLAS PHARMA INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hamaguchi, Wataru Tokyo, JP 13 95
Kawakami, Shimpei Tokyo, JP 9 54
Kawano, Noriyuki Ibaraki, JP 34 368
Moritomo, Ayako Tokyo, JP 8 60
Moritomo, Hiroyuki Tokyo, JP 35 780
Sakurai, Minoru Ibaraki, JP 37 325
Sekioka, Ryuichi Tokyo, JP 3 2
Shiraishi, Nobuyuki Tokyo, JP 14 53
Suzuki, Takayuki Tokyo, JP 640 11105

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00